No more post-implant errors

Clerio is working on a technology to write corrections into some existing intraocular lenses (IOLs). The technology will offer the ability to correct post-implant refractive errors. It can also convert monofocal IOLs into multifocal IOLS. These adjustments can be made over the life of the patient, achieving optimal outcomes in vision correction.

Improving outcomes

More than half of the cataract surgeries performed annually result in a residual refractive error, or the difference between the intended correction and the actual correction. Sometimes this result occurs because an IOL shifts after surgery. Even such a small shift can significantly impact vision. 

Unlike other technologies, LIRIC has a unique capability to write precision corrections into existing IOLs. LIRIC also has the ability to modify prescriptions multiple times without an invasive procedure.

ABOUT CLERIO VISION 

Clerio Vision was founded based on groundbreaking research from the University of Rochester using femtosecond lasers for noninvasive vision correction in contact lenses, the human cornea and intraocular lenses (IOLs). We are dedicated to providing a wide array of solutions to the millions of patients requiring vision correction.

Headquarters 

& Operations

1892 S. Winton Rd.

Rochester, NY 14618

Contact Lens

Manufacturing & Sales

7575 Commerce Court

Sarasota, FL 34243                    

Contact Lens  

Research Center

205 Summit Point Dr.

Henrietta, NY 14467

 

Refractive Surgery

Research Center

1435 Koll Circle Suite 105

San Jose, CA 95112